Blocking CD40-CD154 and CD80/CD86-CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production

European Journal of Immunology

Volumn 29, Issue 8, 1999, Pages 2367-2375

  Van Gool, Stefaan W ^a,d   Vermeiren, Jan ^a   Rafiq, Khadija ^a   Loiré, Katrien ^b   De Boer, Mark ^c   Ceuppens, Jan L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INNOGENETICS   (Belgium)

^c Tanox Pharma BV   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Anergy; CD40; CD80; CD86; Co stimulation

Indexed keywords

ALLOANTIGEN; B7 ANTIGEN; CD28 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 2;

ADULT; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CD40 LIGAND; CLONAL ANERGY; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOCONJUGATES; INTERLEUKIN-10; INTERLEUKINS; ISOANTIGENS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0032773310     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199908)29:08<2367::AID-IMMU2367>3.0.CO;2-3     Document Type: Article

References (54)

1. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R. Q., Gibson, M. L., Zheng, X. G., Myrdal, S., Gordon, D., Bailey, T., Bolling, S. F. and Thompson, C. B., T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 1992. 89: 11102-11105.
2. Lin, H., Bolling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B. and Turka, L. A., Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4lg plus donor-specific transfusion. J. Exp. Med. 1993. 178: 1801-1806.
3. Akalin, E., Chandraker, A., Russell, M. E., Turka, L. A., Hancock, W. W. and Sayegh, M. H., CD28-B7 T cell costimulatory blockade by CTLA4lg in the rat renal allograft model - Inhibition of cell-mediated and humoral immune responses in vivo. Transplantation 1996. 62: 1942-1945.
4. Pescovitz, M. D., Yang, R., Liu, Q., Collins, M. H. and Grosfeld, J. L., CD28-pathway blockade with CTLA4lg leads to prolongation of small bowel transplant survival in rats. Transplant. Proc. 1994. 26: 1618-1619.
5. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A., Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992. 257: 789-792.
6. Pearson, T. C., Alexander, D. Z., Winn, K. J., Linsley, P. S., Lowry, R. P. and Larsen, C. P., Transplantation tolerance induced by CTLA4lg. Transplantation 1994. 57: 1701-1706.
7. Blazar, B. R., Taylor, P. A., Linsley, P. S. and Vallera, D. A., In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-lg reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 1994. 83: 3815-3825.
8. Finck, B. K., Linsley, P. S. and Wofsy, D., Treatment of murine lupus with CTLA4lg. Science 1994. 265: 1225-1227.
9. Milich, D. R., Linsley, P. S., Hughes, J. L. and Jones, J. E., Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model. J. Immunol. 1994. 153: 429-435.
10. Nishikawa, K., Linsley, P. S., Collins, A. B., Stamenkovic, I., McCluskey, R. T. and Andres, G., Effect of CTLA-4 chimeric protein on rat autoimmune antiglomerular basement membrane glomerulonephritis. Eur. J. Immunol. 1994. 24: 1249-1254.
11. Tan, P. Anasetti, C., Hansen, J. A., Melrose, J., Brunvand, M., Bradshaw, J., Ledbetter, J. A. and Linsley, P. S., Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J. Exp. Med. 1993. 177: 165-173.
12. Van Gool, S. W., de Boer, M. and Ceuppens, J. L., The combination of anti-B7 monoclonal antibody and cyclosporin A induces alloantigen-specific anergy during a primary mixed lymphocyte reaction. J. Exp. Med. 1994. 179: 715-720.
13. Hurtado, J. C., Kim, S. H., Pollok, K. E., Lee, Z. H. and Kwon, B. S., Potential role of 4-1BB in T cell activation -Comparison with the costimulatory molecule CD28. J. Immunol. 1995. 155: 3360-3367.
14. + T cells with homology to tumor necrosis factor. J. Exp. Med. 1994. 180: 757-762.
15. Wu, Y., Xu, J., Shinde, S., Grewal, I., Henderson, T., Flavell, R. A. and Liu, Y., Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr. Biol. 1995. 5: 1303-1311.
16. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E. and Noelle, R. J., Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 1996. 14: 591-617.
17. Kiener, P. A., Moran-Davis, P., Rankin, B. M., Wahl, A. F., Aruffo, A. and Hollenbaugh, D., Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 1995. 155: 4917-4925.
18. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994. 180: 1263-1272.
19. Guo, Y., Wu, Y., Shinde, S., Sy, M. S., Aruffo, A. and Liu, Y., Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J. Exp. Med. 1996. 184: 955-961.
20. Kennedy, M. K., Picha, K. S., Fanslow, W. C., Grabstein, K. H., Alderson, M. R., Clifford, K. N., Chin, W. A. and Mohler, K. M., CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 1996. 26: 370-378.
21. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
22. Larsen, C. P., Elwood, E. T., Alexander, D. Z., Ritchie, S. C., Hendrix, R., Tucker-Burden, C., Cho, H. R., Aruffo, A., Hollenbaugh, D., Linsley, P. S., Winn, K. J. and Pearson, T. C., Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996. 381: 434-438.
23. Sun, H., Subbotin, V., Chen, C., Aitouche, A., Valdivia, L. A., Sayegh, M. H., Linsley, P. S., Fung, J. J., Starzl, T. E. and Rao, A. S., Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA-4lg and anti-CD40 ligand monoclonal antibody. Transplantation 1997. 64: 1838-1843.
24. Daikh, D. I., Finck, B. K., Linsley, P. S., Hollenbaugh, D. and Wofsy, D., Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J. Immunol. 1997. 159: 3104-3108.
25. Tang, A. M., Judge, T. A., Nickoloff, B. J. and Turka, L. A., Suppression of murine allergic contact dermatitis by CTLA-4lg - Tolerance induction of the Th2 responses requires additional blockade of CD40-ligand. J. Immunol. 1996. 157: 117-125.
26. Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D., Rechner, J. H., Jr. and Knechtle, S. J., CTLA-4lg and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 1997. 94: 8789-8794.
27. Saito, K., Sakurai, J., Ohata, J., Kohsaka, T., Hashimoto, H., Okumura, K., Abe, R. and Azuma, M., Involvement of CD40 ligand CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. J. Immunol. 1998. 160: 4225-4231.
28. de Boer, M., Conroy, L, Min, H. Y. and Kwekkeboom, J., Generation of monoclonal antibodies to human lymphocyte cell surface antigens using insect cells expressing recombinant proteins. J. Immunol. Methods 1992. 152: 15-23.
29. Kwekkeboom, J., de Rijk, D., Kasran, A., Barcy, S., De Groot, C. and de Boer, M., Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40 - CD40 ligand interaction. Eur. J. Immunol. 1994. 24: 508-517.
30. Van Gool, S. W., Kasran, A., Wallays, G., de Boer, M. and Ceuppens, J. L., Accessory signalling by B7-1 for T cell activation induced by anti-CD2: evidence for IL-2-independent CTL generation and CsA-resistant cytokine production. Scand. J. Immunol. 1995. 41: 23-30.
31. Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Chused, T. M. and Schwartz, R. H., Molecular events in the induction of a non responsive state in IL-2 producing helper T lymphocyte clones. Proc. Natl. Acad. Sci. USA 1987. 54: 5409-5400.
32. Schwartz, R. H., Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992. 71: 1065-1068.
33. Boussiotis, V. A., Barber, D. L., Nakarai, T., Freeman, G. J., Gribben, J. G., Bernstein G. M., D'Andrea, A. D., Ritz, J. and Nadler, L. M., Prevention of T cell anergy by signaling through the βc chain of the IL-2 receptor. Science 1994. 266: 1039-1042.
34. Schwartz, R. H., Models of T cell anergy: Is there a common molecular mechanism? J. Exp. Med. 1996. 184: 1-8.
35. + T cell-mediated graft rejection. Eur. J. Immunol. 1997. 27: 1663-1670.
36. Onodera, K., Hancock, W. W., Graser, E., Lehmann, M., Sayegh, M. H., Strom, T. B., Volk, H. D. and Kupiec-Weglinski, J. W., Type 2 helper T cell-type cytokines and the development of infectious tolerance in rat cardiac allograft recipients. J. Immunol. 1997. 185: 1572-1581.
37. Konieczny, B. T., Dai, Z. H., Elwood, E. T., Saleem, S., Linsley, P. S., Baddoura, F. K., Larsen, C. P., Pearson, T. C. and Lakkis, F. G., IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 1998. 160: 2059-2064.
38. + T cells, interferon-γ and CTLA4. J. Clin. Invest. 1998. 101: 2446-2455.
39. Paineau, J., Priestley, C., Fabre, J., Chevalier, S., van der Meide, P., Schellekens, H., Jacques, Y. and Soulillou, J. P., Effect of recombinant Interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts. J. Heart Lung Transplant. 1991. 10: 424-430.
40. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A. and Stewart, T. A., Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993. 259: 1693-1694.
41. Schandené, L., Alonso-Vega, C., Willems, F., Gérard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M. and Goldman, M., B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 1994. 152: 4368-4374.
42. Rafiq, K., Kasran, A., Peng, X., Warmerdam, P. A. M., Coorevits, L., Ceuppens, J. L. and Van Gool, S. W., Cyclosporin-A increases interferon-gamma production by T cells when costimulated through CD28. Eur. J. Immunol. 1998. 28: 1481-1491.
43. Buer, J., Lanoue, A., Franzke, A., Garcia, C., von Boehmer, H. and Sarukhan, A., Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 1998. 187: 177-183.
44. Chandraker, A., Azuma, H., Nadeau, K., Carpenter, C. B., Tilney, N. L., Hancock, W. W. and Sayegh, M. H., Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J. Clin. Invest. 1998. 101: 2309-2318.
45. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. and Enk, A. H., Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997. 159: 4772-4780.
46. Armitage, R. J., Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 1994. 6: 407-413.
47. Debenedette, M. A., Shahinian, A., Mak, T. W. and Watts, T. H., Costimulation of CD28 T lymphocytes by 4-1BB ligand. J. Immunol. 1997. 158: 551-559.
48. Fuleihan, R., Ramesh, N., Horner, A., Ahern, D., Belshaw, P. J., Alberg, D. G., Stamenkovic, I., Harmon, W. and Geha, R. S., Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 1994. 93: 1315-1320.
49. Van Essen, D., Kikutani, H. and Gray, D., CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995. 378: 620-623.
50. Peng, X. H., Kasran, A., Warmerdam, P. A. M., de Boer, M. and Ceuppens, J. L., Accessory signaling by CD40 for T cell activation: Induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 1996. 26: 1621-1627.
51. + T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science 1991. 251: 1228-1231.
52. Go, C., Lancki, D. W., Fitch, F. W. and Miller, J., Anergized T cell clones retain their cytolytic ability. J. Immunol. 1993. 150: 367-376.
53. de Boer, M., Parren, P., Dove, J., Ossendorp, P., van der Horst, G. and Reeder, J., Functional characterization of a novel anti-B7 monoclonal antibody. Eur. J. Immunol. 1992. 22: 3071-3075.
54. Van Gool, S. W., de Boer, M. and Ceuppens, J. L., CD28 ligation by mAb or B7/BB1 provides an accessory signal for the CsA-resistant generation of cytotoxic T cell activity. J. Immunol. 1993. 150: 3254-3263.